177 related articles for article (PubMed ID: 12382209)
1. Mood disorders: treatment-induced changes in brain neurochemistry and structure.
Glitz DA; Manji HK; Moore GJ
Semin Clin Neuropsychiatry; 2002 Oct; 7(4):269-80. PubMed ID: 12382209
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders.
Moore GJ; Galloway MP
Psychopharmacol Bull; 2002; 36(2):5-23. PubMed ID: 12397837
[TBL] [Abstract][Full Text] [Related]
3. In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium.
Kilts CD
J Clin Psychiatry; 2000; 61 Suppl 9():41-6. PubMed ID: 10826660
[TBL] [Abstract][Full Text] [Related]
4. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
Manji HK; Duman RS
Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance spectroscopy in affective disorders.
Kato T; Inubushi T; Kato N
J Neuropsychiatry Clin Neurosci; 1998; 10(2):133-47. PubMed ID: 9608402
[TBL] [Abstract][Full Text] [Related]
6. Application of magnetic resonance spectroscopy in geriatric mood disorders.
Mathias LK; Monette PJ; Harper DG; Forester BP
Int Rev Psychiatry; 2017 Dec; 29(6):597-617. PubMed ID: 29199890
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders.
Cecil KM; DelBello MP; Sellars MC; Strakowski SM
J Child Adolesc Psychopharmacol; 2003; 13(4):545-55. PubMed ID: 14977467
[TBL] [Abstract][Full Text] [Related]
8. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
9. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
10. Recent neurochemical and pharmacological aspects of pathogenesis and therapy of affective psychoses.
Emrich HM; Wolf R
Pharmacol Toxicol; 1990; 66 Suppl 3():5-12. PubMed ID: 2179931
[TBL] [Abstract][Full Text] [Related]
11. Novel drugs and therapeutic targets for severe mood disorders.
Mathew SJ; Manji HK; Charney DS
Neuropsychopharmacology; 2008 Aug; 33(9):2080-92. PubMed ID: 18172433
[TBL] [Abstract][Full Text] [Related]
12. Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium.
Sakrajda K; Szczepankiewicz A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546417
[TBL] [Abstract][Full Text] [Related]
13. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness.
Manji HK; Moore GJ; Chen G
Biol Psychiatry; 2000 Oct; 48(8):740-54. PubMed ID: 11063971
[TBL] [Abstract][Full Text] [Related]
14. Morphological brain changes in depression: can antidepressants reverse them?
Miguel-Hidalgo JJ; Rajkowska G
CNS Drugs; 2002; 16(6):361-72. PubMed ID: 12027783
[TBL] [Abstract][Full Text] [Related]
15. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
Gray NA; Zhou R; Du J; Moore GJ; Manji HK
J Clin Psychiatry; 2003; 64 Suppl 5():3-17. PubMed ID: 12720479
[TBL] [Abstract][Full Text] [Related]
16. Cell pathology in mood disorders.
Rajkowska G
Semin Clin Neuropsychiatry; 2002 Oct; 7(4):281-92. PubMed ID: 12382210
[TBL] [Abstract][Full Text] [Related]
17. Clinical studies implementing glutamate neurotransmission in mood disorders.
Sanacora G; Rothman DL; Mason G; Krystal JH
Ann N Y Acad Sci; 2003 Nov; 1003():292-308. PubMed ID: 14684453
[TBL] [Abstract][Full Text] [Related]
18. Lithium's role in neural plasticity and its implications for mood disorders.
Gray JD; McEwen BS
Acta Psychiatr Scand; 2013 Nov; 128(5):347-61. PubMed ID: 23617566
[TBL] [Abstract][Full Text] [Related]
19. The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?
Jeon WJ; Dean B; Scarr E; Gibbons A
Curr Neuropharmacol; 2015; 13(6):739-49. PubMed ID: 26630954
[TBL] [Abstract][Full Text] [Related]
20. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders.
Soares JC; Krishnan KR; Keshavan MS
Depression; 1996; 4(1):14-30. PubMed ID: 9160650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
